Hypothesis paper · with references
Idiopathic Pulmonary Fibrosis as a Neurologically Driven “Stuck” Repair Response
The full argument: endocrine clues outside the lung, the brain’s control of wound healing, evidence from PTSD and stress-induced heart fibrosis, and the glial “stuck signal” mechanism.
Read the full paper
Introduction
Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease of unknown cause, characterized by relentless scarring (fibrosis) of the lung tissue. Despite extensive research, IPF’s origin remains elusive: patients’ lungs undergo continual scar formation without a clear ongoing injury. Traditional hypotheses focus on repeated microscopic lung injuries and aberrant wound healing. Here I explore an alternate hypothesis: that IPF is fundamentally a neurologically driven disorder, a chronic “stuck” repair response initiated by the brain’s stress and autonomic systems, analogous to a prolonged fight-or-flight or trauma response. In this view, the brain and autonomic nervous system continuously signal the lungs to produce scar tissue, even in the absence of local damage, much like a faulty switch stuck in the “on” position.
Clues beyond the lung: endocrine and systemic links
One clue that IPF may not be solely a lung-localized problem is its association with systemic endocrine changes. Thyroid dysfunction is more common in IPF patients than in the general population. A 2015 study found that thyroid disease is prevalent in IPF patients and predicts their survival (Oldham et al.). Many IPF patients show subclinical or overt hypothyroidism (elevated TSH), and those abnormalities correlated with worse lung function (lower FVC and FEV₁). These observations hint that IPF may involve dysregulation of the body’s hormonal or metabolic state, rather than being a purely local lung issue.
There is also experimental evidence that restoring thyroid hormone can directly affect lung fibrosis. In a preclinical study (Yu et al., Nature Medicine, 2018), inhaled active thyroid hormone (T3) significantly reversed established fibrosis and increased survival in mice. The same study found that IPF lungs show increased expression of DIO2, an enzyme that activates thyroid hormone, suggesting the body may be trying to counteract fibrosis by ramping up local hormone activation. That augmenting a systemic hormone can halt or undo lung scarring supports the idea that fibrosis is driven by a systemic signal or imbalance, and implies a brain–thyroid–lung axis: the hypothalamus and pituitary, which regulate the thyroid through TSH, may be part of the loop that governs lung repair.
A further observation: replacing the lungs by transplant does not always remove the problem. Full recurrence of IPF in a transplanted lung is considered rare, and is likely damped by post-transplant immunosuppression (Elicker et al., 2010), but reports of fibrotic processes continuing suggest that something in the patient’s internal environment can still drive scarring after the original lungs are gone. The propensity for pathologic scarring may reside in the person, not only in the removed tissue.
The brain’s role in wound healing and stress
The limbic system, including the amygdala, hypothalamus, pituitary and hippocampus, is the command centre for the stress response. Under acute danger it releases hormones and neurotransmitters such as adrenaline and cortisol, and it triggers automatic repair if injury occurs. These responses are involuntary and normally tightly regulated: the hippocampus provides negative feedback that shuts the stress response off once a threat has passed (Herman et al., 2016).
Under chronic stress this regulation can fail. Prolonged stress is associated with a smaller hippocampus (Logue et al., 2018) and a weakened ability to switch off the hypothalamic–pituitary–adrenal (HPA) axis. The result, seen in post-traumatic stress disorder, is a body held in persistent fight-or-flight, with chronic release of stress mediators (Elenkov & Chrousos, 2004; Dhabhar, 2014).
Those mediators include pro-inflammatory and pro-fibrotic molecules. Prolonged sympathetic activation skews immune signalling toward chronic low-grade inflammation, and chronic stress has been shown to stimulate a pro-fibrotic pathway in lung and heart (Chen et al., 2015). Among the cytokines involved is transforming growth factor beta 1 (TGF-β1), the master regulator of fibrosis, which drives fibroblasts to produce collagen and scar matrix (Fernandez & Eickelberg, 2012). Blocking TGF-β signalling in lung epithelium protects mice from bleomycin-induced fibrosis (Li et al., 2011). Put together: chronic stress → sympathetic overactivity → excess TGF-β1 → unrestrained fibrosis.
Evidence from PTSD and chronic stress on other organs
People with PTSD show elevated inflammatory markers and a higher incidence of heart disease. In a 2020 rat model of PTSD, predator-induced stress alone, with no physical injury to the heart, produced multifocal cardiac lesions with necrosis, immune cell infiltration and collagen deposition, along with markers of fibroblast activation (Rorabaugh et al., 2020). Chronic psychological stress was enough to scar heart tissue.
If stress signals can scar a heart, the lungs are a plausible target too: they are richly innervated by vagal and sensory nerves that take part in injury responses (Mazzone & Undem, 2016), and IPF patients show a heightened cough reflex (Hope-Gill et al., 2003). In this hypothesis the limbic and autonomic system is the initiator: after trauma, chronic anxiety or another neurological insult, the brain keeps the lungs in “repair mode”, and lung tissue keeps depositing collagen as if healing an injury that isn’t there. A testable prediction follows: IPF patients should show higher rates of prior severe stress or trauma than matched controls.
Glia, neuroplasticity and the “stuck signal”
Glial cells, especially astrocytes and microglia, maintain neuronal health, clear neurotransmitters such as glutamate, and regulate the blood–brain barrier. Chronic stress changes microglia in stress-responsive brain regions (Tynan et al., 2010). If glial clearance fails, circuits may not shut off properly: a limbic circuit could keep firing a “damage–repair” signal, like a broken thermostat, and some part of the brain would keep telling the lungs “heal, heal, heal” when no healing is needed.
The brain is also plastic. Rehabilitation remodels circuits after stroke, exposure therapy rewires fear circuits in PTSD, and psilocybin has been shown to induce rapid, persistent growth of dendritic spines (Shao et al., 2021). Future IPF care could pair anti-fibrotic drugs with approaches that target the brain: stress reduction, neurofeedback, or neuromodulatory treatment, alongside pulmonary rehabilitation.
Conclusion
The hypothesis that IPF is at its core a neurologically driven process, a chronic stress injury expressed in the lung, offers a new perspective on a devastating disease. It rests on evidence that chronic stress and autonomic dysregulation can induce fibrosis elsewhere in the body, and that IPF is linked to systemic dysfunction such as thyroid imbalance. Validating it needs rigorous work: epidemiological studies of trauma in fibrotic disease, biological studies of neural and hormonal activity in IPF patients, and trials of stress-targeted interventions. If it holds, “idiopathic” diseases like IPF could come to be understood as neuro-immune maladaptations, and that would give patients something long missing: new ways to treat the cause.
References (published studies by other researchers, cited in the paper)
- Oldham JM, Kumar D, Lee C, et al. Thyroid disease is prevalent and predicts survival in patients with idiopathic pulmonary fibrosis. Chest. 2015;148(3):692–700.
- Yu G, Tzouvelekis A, Wang R, et al. Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function. Nat Med. 2018;24(1):39–49.
- Elicker BM, Golden JA, Ordovas KG, et al. Progression of native lung fibrosis in lung transplant recipients with idiopathic pulmonary fibrosis. Respir Med. 2010;104(3):426–433.
- Herman JP, McKlveen JM, Ghosal S, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603–621.
- Logue MW, van Rooij SJ, Dennis EL, et al. Smaller hippocampal volume in posttraumatic stress disorder: a multisite ENIGMA-PGC study. Biol Psychiatry. 2018;83(3):244–253.
- Elenkov IJ, Chrousos GP. Stress system activation and immunity: implications for inflammation, autoimmune diseases, and health. Ann N Y Acad Sci. 2004;1024:1–12.
- Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. 2014;58(2-3):193–210.
- Chen WS, Zhang C, Pang J, et al. Chronic stress stimulates a pro-fibrotic pathway in lung and heart. Sci Rep. 2015;5:16691.
- Fernandez IE, Eickelberg O. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc. 2012;9(3):111–116.
- Li M, Krishnaveni MS, Li C, et al. Epithelium-specific deletion of TGF-β receptor type II protects mice from bleomycin-induced pulmonary fibrosis. J Clin Invest. 2011;121(1):277–287.
- Rorabaugh BR, Mabe NW, Seeley SL, et al. Myocardial fibrosis, inflammation, and altered cardiac gene expression profiles in rats exposed to a predator-based model of posttraumatic stress disorder. Stress. 2020;23(2):125–135.
- Mazzone SB, Undem BJ. Vagal afferent innervation of the airways in health and disease. Physiol Rev. 2016;96(3):975–1024.
- Hope-Gill BD, Hilldrup S, Davies C, et al. A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168(8):995–1002.
- Tynan RJ, Naicker S, Hinwood M, et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun. 2010;24(7):1058–1068.
- Shao LX, Liao C, Gregg I, et al. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. Neuron. 2021;109(16):2535–2544.


